T46.4X2 类别:需要更具体的编码 Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
ICD-10-CM T46.4X2 identifies “Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 19: Injury, poisoning and certain other consequences of external causes
编码说明
无额外说明。
上级编码说明
章节 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T46 · Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
Excludes 11
poisoning by, adverse effect of and underdosing of metaraminol (T44.4)
Seventh character1
The appropriate 7th character is to be added to each code from category T46
A — initial encounter
D — subsequent encounter
S — sequela
更具体的编码
T46.4X2APoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter可计费的具体编码T46.4X2DPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter可计费的具体编码T46.4X2SPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela可计费的具体编码官方索引引用
官方索引引用 (15)
Alacepril (1)
- Alacepril药物和化学物质
Benazepril (1)
- Benazepril药物和化学物质
Captopril (1)
- Captopril药物和化学物质
Cilazapril (1)
- Cilazapril药物和化学物质
Enalapril (1)
- Enalapril药物和化学物质
Enalaprilat (1)
- Enalaprilat药物和化学物质
Fosinopril (2)
- Fosinopril药物和化学物质
- Fosinopril › sodium药物和化学物质
Inhibitor (1)
Lisinopril (1)
- Lisinopril药物和化学物质
Perindopril (1)
- Perindopril药物和化学物质
Quinapril (1)
- Quinapril药物和化学物质
Ramipril (1)
- Ramipril药物和化学物质
Spirapril (1)
- Spirapril药物和化学物质
Zofenopril (1)
- Zofenopril药物和化学物质
历史
编码历史
最近记录的变更 · FY2025 · 04-01
生效日期
- 上级说明变更
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
类别 — 请选择更具体的编码
CDC/NCHS · FY2025 · 04-01所有版本 (19)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 分类表无变更 |
| FY2018 | 2017-10-01 | 分类表无变更 |
| FY2019 | 2018-10-01 | 上级说明变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 上级说明变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 分类表无变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 分类表无变更 |
| FY2025 · 04-01 | 2025-04-01 | 上级说明变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
浏览此类别中更具体的编码。 参考核验不能确定临床适用性,也不保证报销。